1 year return (CAGR)
-26.86%
Recursion Pharmaceuticals Inc Exchange (NASDAQ, USD)
RXRX
3.70
+0.35 (+10.97%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-25.47%
5 year return (CAGR)
-34.26%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.90B
Price/Sales
34.55
Ent value
1.65B
Price/Book
2.07
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
13.25%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.29 |
| Daily high | 3.59 |
| Daily low | 3.26 |
| Daily Volume | 28.1M |
| All-time high | 41.33 |
| 1y analyst estimate | 7.22 |
| Beta | 1.05 |
| EPS (TTM) | -0.97 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 4 Mar 2026 |
Downside potential
Loading...
Downside potential data
| RXRX | S&P500 | |
| Current price drop from All-time high | -91.05% | -1.29% |
| Highest price drop | -93.13% | -56.47% |
| Date of highest drop | 30 Mar 2026 | 9 Mar 2009 |
| Avg drop from high | -76.17% | -10.68% |
| Avg time to new high | 97 days | 12 days |
| Max time to new high | 1302 days | 1805 days |
News
